Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?-Reference-Cited by-同舟云学术

Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?

Published:2023-12 Issue: Volume:121 Page:102650
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Incorvaia Lorena,Perez Alessandro,Marchetti Claudia,Brando Chiara,Gristina Valerio,Cancelliere Daniela,Pivetti Alessia,Contino Silvia,Di Giovanni Emilia,Barraco Nadia,Bono Marco,Giurintano Ambra,Bazan Russo Tancredi Didier,Gottardo Andrea,Cutaia Sofia,Pedone Erika,Peri Marta,Corsini Lidia Rita,Fanale Daniele,Galvano Antonio,Scambia Giovanni,Badalamenti Giuseppe,Russo Antonio,Bazan Viviana

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference118 articles.

1. Hereditary breast and ovarian cancer: new genes in confined pathways;Nielsen;Nat Rev Cancer,2016

2. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy;Farmer;Nature,2005

3. A decade of clinical development of PARP inhibitors in perspective;Mateo;Ann Oncol,2019

4. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies;Russo;ESMO Open,2022

5. Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge;Bono;ESMO Open,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors;npj Precision Oncology;2024-09-05

2. Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors;Cancer Gene Therapy;2024-08-09

3. Somatic and germline aberrations in homologous recombination repair genes among Chinese high-risk breast cancer patients by multi-gene next-generation sequencing;Clinical and Translational Oncology;2024-07-24

4. Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives;Current Opinion in Oncology;2024-06-13

5. Genomic Features of Homologous Recombination Deficiency in Breast Cancer: Impact on Testing and Immunotherapy;Genes;2024-01-26